|
1
|
Globocan 2012: Estimated cancer incidence,
mortality and prevalence worldwide in 2012 (Internet). (Lyon).
International Agency for Research on Cancer. 2013.http://globocan.iarc.fr
|
|
2
|
Sakuramoto S, Sasako M, Yamaguchi T,
Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi
Y, Imamura H, et al: Adjuvant chemotherapy for gastric cancer with
S-1, an oral fluoropyrimidine. N Engl J Med. 357:1810–1820. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
GASTRIC (Global Advanced/Adjuvant Stomach
Tumor Research International Collaboration) Group, ; Oba K,
Paoletti X, Bang YJ, Bleiberg H, Burzykowski T, Fuse N, Michiels S,
Morita S, Ohashi Y, et al: Role of chemotherapy for
advanced/recurrent gastric cancer: An individual-patient-data
meta-analysis. Eur J Cancer. 49:1565–1577. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Terashima M, Ichikawa W, Ochiai A, Kitada
K, Kurahashi I, Sakuramoto S, Katai H, Sano T, Imamura H and Sasako
M; ACTS-GC Group, : TOP2A, GGH, and PECAM1 are associated with
hematogenous, lymph node, and peritoneal recurrence in stage II/III
gastric cancer patients enrolled in the ACTS-GC study. Oncotarget.
8:57574–57582. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heber D, Byerly LO and Chlebowski RT:
Metabolic abnormalities in the cancer patient. Cancer. 55 Suppl
1:S225–S229. 1985. View Article : Google Scholar
|
|
6
|
Stockert E, Jäger E, Chen YT, Scanlan MJ,
Gout I, Karbach J, Arand M, Knuth A and Old LJ: A survey of the
humoral immune response of cancer patients to a panel of human
tumor antigens. J Exp Med. 187:1349–1354. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dranoff G: Cytokines in cancer
pathogenesis and cancer therapy. Nat Rev Cancer. 4:11–22. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Holmgren L, O'Reilly MS and Folkman J:
Dormancy of micrometastases: Balanced proliferation and apoptosis
in the presence of angiogenesis suppression. Nat Med. 1:149–153.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maeda K, Chung YS, Ogawa Y, Takatsuka S,
Kang SM, Ogawa M, Sawada T and Sowa M: Prognostic value of vascular
endothelial growth factor expression in gastric carcinoma. Cancer.
77:858–863. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park DJ, Thomas NJ, Yoon C and Yoon SS:
Vascular endothelial growth factor an inhibition in gastric cancer.
Gastric Cancer. 18:33–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee EY, Cibull ML, Strodel WE and Haley
JV: Expression of HER-2/neu oncoprotein and epidermal growth factor
receptor and prognosis in gastric carcinoma. Arch Pathol Lab Med.
118:235–239. 1994.PubMed/NCBI
|
|
14
|
Lordick F: Targeting the HGF/MET pathway
in gastric cancer. Lancet Oncol. 15:914–916. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Chang Y, Xu J and Zhang Q:
Predictive significance of serum level of vascular endothelial
growth factor in gastric cancer patients. Biomed Res Int 2016.
81030192016.
|
|
16
|
Karayiannakis AJ, Syrigos KN,
Polychronidis A, Zbar A, Kouraklis G, Simopoulos C and Karatzas G:
Circulating VEGF levels in the serum of gastric cancer patients:
Correlation with pathological variables, patient survival, and
tumor surgery. Ann Surg. 236:37–42. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park DJ, Seo AN, Yoon C, Ku GY, Coit DG,
Strong VE, Suh YS, Lee HS, Yang HK, Kim HH and Yoon SS: Serum
VEGF-A and tumor vessel VEGFR-2 levels predict survival in
caucasian but not asian patients undergoing resection for gastric
adenocarcinoma. Ann Surg Oncol. 22 Suppl 3:S1508–S15015. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jüttner S, Wissmann C, Jöns T, Vieth M,
Hertel J, Gretschel S, Schlag PM, Kemmner W and Höcker M: Vascular
endothelial growth factor-D and its receptor VEGFR-3: Two novel
independent prognostic markers in gastric adenocarcinoma. J Clin
Oncol. 24:228–240. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Axel L: Cerebral blood flow determination
by rapid-sequence computed tomography: Theoretical analysis.
Radiology. 137:679–686. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miles KA, Hayball M and Dixon AK: Colour
perfusion imaging: A new application of computed tomography.
Lancet. 337:643–645. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ronot M, Asselah T, Paradis V, Michoux N,
Dorvillius M, Baron G, Marcellin P, Van Beers BE and Vilgrain V:
Liver fibrosis in chronic hepatitis C virus infection:
Differentiating minimal from intermediate fibrosis with perfusion
CT. Radiology. 256:135–142. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hashimoto K, Murakami T, Dono K, Hori M,
Kim T, Kudo M, Marubashi S, Miyamoto A, Takeda Y, Nagano H, et al:
Assessment of the severity of liver disease and fibrotic change:
The usefulness of hepatic CT perfusion imaging. Oncol Rep.
16:677–683. 2006.PubMed/NCBI
|
|
23
|
Hayano K, Okazumi S, Shuto K, Matsubara H,
Shimada H, Nabeya Y, Kazama T, Yanagawa N and Ochiai T: Perfusion
CT can predict the response to chemoradiation therapy and survival
in esophageal squamous cell carcinoma: Initial clinical results.
Oncol Rep. 18:901–908. 2007.PubMed/NCBI
|
|
24
|
Satoh A, Shuto K, Okazumi S, Ohira G,
Natsume T, Hayano K, Narushima K, Saito H, Ohta T, Nabeya Y, et al:
Role of perfusion CT in assessing tumor blood flow and malignancy
level of gastric cancer. Dig Surg. 27:253–260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
García-Figueiras R, Goh VJ, Padhani AR,
Baleato-González S, Garrido M, León L and Gómez-Caamaño A: CT
perfusion in oncologic imaging: A useful tool? AJR Am J Roentgenol.
200:8–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
James DB, Mary KG and Christian W: TNM
Classification of Malignant Tumours. (8th). Wiley-Liss. (New York).
2017.
|
|
27
|
Japanese Gastric Cancer Association:
Japanese Classification of Gastric Carcinoma. (15th). Kanehara
Publisher. (Tokyo). 27–23. 2017.
|
|
28
|
Meier P and Zierler KL: On the theory of
the indicator-dilution method for measurement of blood flow and
volume. J Appl Physiol. 6:731–744. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hayano K, Fujishiro T, Sahani DV, Satoh A,
Aoyagi T, Ohira G, Tochigi T, Matsubara H and Shuto K: Computed
tomography perfusion imaging as a potential imaging biomarker of
colorectal cancer. World J Gastroenterol. 20:17345–17351. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kruk-Bachonko J, Krupski W, Czechowski M,
Kurys-Denis E, Mądro P, Sierocińska-Sawa J, Dąbrowski A, Wallner G
and Skoczylas T: Perfusion CT-A novel quantitative and qualitative
imaging biomarker in gastric cancer. Eur J Radiol. 95:399–408.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leveson SH, Wiggins PA, Giles GR, Parkin A
and Robinson PJ: Deranged liver blood flow patterns in the
detection of liver metastases. Br J Surg. 72:128–130. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Leen E, Goldberg JA, Robertson J,
Sutherland GR and McArdle CS: The use of duplex sonography in the
detection of colorectal hepatic metastases. Br J Cancer.
63:323–325. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miles KA, Hayball MP and Dixon AK:
Functional images of hepatic perfusion obtained with dynamic CT.
Radiology. 188:405–411. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nott DM, Grime SJ, Yates J, Day DW, Baxter
JN, Jenkins SA and Cooke TG: Changes in the hepatic perfusion index
during the development of experimental hepatic tumours. Br J Surg.
76:259–263. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Leggett DA, Kelley BB, Bunce IH and Miles
KA: Colorectal cancer: Diagnostic potential of CT measurements of
hepatic perfusion and implications for contrast enhancement
protocols. Radiology. 205:716–720. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cuenod CA, Leconte I, Siauve N, Resten A,
Dromain C, Poulet B, Frouin F, Clément O and Frija G: Early changes
in liver perfusion caused by occult metastases in rats: Detection
with quantitative CT. Radiology. 218:556–561. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cunningham D, Allum WH, Stenning SP,
Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ,
Falk SJ, Iveson TJ, et al: Perioperative chemotherapy versus
surgery alone for resectable gastroesophageal cancer. N Engl J Med.
355:11–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yoshikawa T, Sasako M, Yamamoto S, Sano T,
Imamura H, Fujitani K, Oshita H, Ito S, Kawashima Y and Fukushima
N: Phase II study of neoadjuvant chemotherapy and extended surgery
for locally advanced gastric cancer. Br J Surg. 96:1015–1012. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Smalley SR, Benedetti JK, Haller DG,
Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson
JA, Jessup JM, et al: Updated analysis of SWOG-directed intergroup
study 0116: A phase III trial of adjuvant radiochemotherapy versus
observation after curative gastric cancer resection. J Clin Oncol.
30:2327–2333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fujishiro T, Shuto K, Hayano K, Satoh A,
Kono T, Ohira G, Tohma T, Gunji H, Narushima K, Tochigi T, et al:
Preoperative hepatic CT perfusion as an early predictor for the
recurrence of esophageal squamous cell carcinoma: Initial clinical
results. Oncol Rep. 31:1083–1088. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Salven P, Orpana A and Joensuu H:
Leukocytes and platelets of patients with cancer contain high
levels of vascular endothelial growth factor. Clin Cancer Res.
5:487–491. 1999.PubMed/NCBI
|
|
42
|
Lee JK, Hong YJ, Han CJ, Hwang DY and Hong
SI: Clinical usefulness of serum and plasma vascular endothelial
growth factor in cancer patients: Which is the optimal specimen?
Int J Oncol. 17:149–152. 2000.PubMed/NCBI
|
|
43
|
Browder T, Folkman J and Pirie-Shepherd S:
The hemostatic system as a regulator of angiogenesis. J Biol Chem.
275:1521–1524. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hejna M, Raderer M and Zielinski CC:
Inhibition of metastases by anticoagulants. J Natl Cancer Inst.
91:22–36. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Takahashi Y, Takeuchi T, Sakamoto J, Touge
T, Mai M, Ohkura H, Kodaira S, Okajima K and Nakazato H; Tumor
Marker Committee, : The usefulness of CEA and/or CA19-9 in
monitoring for recurrence in gastric cancer patients: A prospective
clinical study. Gastric Cancer. 6:142–145. 2003. View Article : Google Scholar : PubMed/NCBI
|
